ENTA logo
Enanta Pharmaceuticals, Inc.(ENTA)
Last print unknown agoAbout this dataData status
$11.41▲0.31 (2.79%)Stale · unknown old

ENTA Total Non-Current Liabilities

$141.64MQuarterly · USD

Period ending:

ENTA FY Total Non-Current LiabilitiesUSD
ENTA FY Total Non-Current Liabilities2011-09-30: $155.91M2012-09-30: $2.50M2013-09-30: $1.98M2014-09-30: $2.02M2015-09-30: $3.15M2016-09-30: $3.45M2017-09-30: $3.98M2018-09-30: $4.52M2019-09-30: $4.73M2020-09-30: $11.05M2021-09-30: $5.26M2022-09-30: $29.43M2023-09-30: $182.75M2024-09-30: $190.30M2025-09-30: $167.46M$190.30M$0.00
2011-09-302025-09-30

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

ENTA total non-current liabilities history

Long-term obligations due beyond one year. The available annual fiscal periods series contains 15 observations from Sep 30, 2011 to Sep 30, 2025.

Enanta Pharmaceuticals Inc Total Non-Current Liabilities — Annual fiscal periods (USD)
Period endingTotal Non-Current Liabilities (USD)
167,459,999
190,303,000
182,753,000
29,429,000
5,260,000
11,052,000
4,728,000
4,523,000
3,979,000
3,452,000
3,152,000
2,015,000
1,979,000
2,499,000
155,908,000

Compare total non-current liabilities

All ENTA financial metrics · ENTA stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.